Recurrence Patterns and Disease-Free Survival after Resection of Intrahepatic Cholangiocarcinoma: Preoperative and Postoperative Prognostic Models

被引:130
作者
Doussot, Alexandre [1 ,6 ]
Gonen, Mithat [2 ]
Wiggers, Jimme K. [1 ]
Groot-Koerkamp, Bas [1 ]
DeMatteo, Ronald P. [1 ]
Fuks, David [3 ]
Allen, Peter J. [1 ]
Farges, Olivier [4 ]
Kingham, T. Peter [1 ]
Regimbeau, Jean Marc [5 ]
D'Angelica, Michael I. [1 ]
Azoulay, Daniel [6 ]
Jarnagin, William R. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Biostat, New York, NY 10021 USA
[3] Paris Descartes Univ, Inst Mutualiste Montsouris, Dept Digest Pathol, Paris, France
[4] Univ Paris 07, Hop Beaujon, AP HP, Dept Hepatobiliary Surg, Clichy, France
[5] CHU Amiens, Dept Surg, Amiens, France
[6] Hop Henri Mondor, AP HP, Dept Hepatobiliary Surg & Liver Transplantat, Creteil, France
关键词
LONG-TERM SURVIVAL; Y-90; RADIOEMBOLIZATION; REGIONAL CHEMOTHERAPY; STAGING SYSTEM; OUTCOMES; MANAGEMENT; BIOMARKER; NOMOGRAM; CANCER;
D O I
10.1016/j.jamcollsurg.2016.05.019
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Liver resection is the most effective treatment for intrahepatic cholangiocarcinoma. Recurrent disease is frequent; however, recurrence patterns are ill-defined and prognostic models are lacking. STUDY DESIGN: A primary cohort of 189 patients who underwent resection for intrahepatic cholangiocarcinoma was used for recurrence patterns analysis within and after 24 months. Based on independent factors for disease-free survival identified in Cox regression analysis, preoperative and postoperative models were developed using a recursive partitioning method. Models were externally validated using a multicenter cohort of 522 resected patients (Association Francaise de Chirurgic intrahepatic cholangiocarcinoma study group). RESULTS: Recurrence within 24 months most often involved the liver (82.7%), and most recurrences after 24 months were strictly extrahepatic (61.1%). In multivariable analysis of the primary cohort, independent preoperative factors for disease-free survival were tumor size and multifocality (based on imaging); tumor size, multifocality, vascular invasion, and lymph node metastases (based on pathology) were independent postoperative factors. The preoperative model allowed patient classification into low-risk and high-risk groups for recurrence. In the validation cohort (n = 522), high-risk patients had a greater likelihood of recurrence (hazard ratio = 2.17; 95% CI, 1.74-2.72; p < 0.001). The postoperative model included tumor size, vascular invasion, and positive nodal disease on pathology and classified patients in low-, intermediate-, and high-risk groups in the primary cohort. As compared with low-risk patients in the validation cohort, intermediate-and high-risk patients were more likely to experience recurrence (hazard ratio = 1.9; 95% CI, 1.41-2.47; p < 0.001 and hazard ratio = 2.99; 95% CI, 2.08-4.31; p < 0.001, respectively). CONCLUSIONS: Recurrence patterns are time dependent. Both models as developed and validated in this study classified patients in distinct recurrence risk groups, which can guide treatment recommendations. (C) 2016 by the American College of Surgeons. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:493 / U251
页数:15
相关论文
共 40 条
[1]   Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: A systematic review and pooled analysis [J].
Al-Adra, D. P. ;
Gill, R. S. ;
Axford, S. J. ;
Shi, X. ;
Kneteman, N. ;
Liau, S. -S. .
EJSO, 2015, 41 (01) :120-127
[2]  
[Anonymous], ANN SURG
[3]  
[Anonymous], HEP ART INF FLOX DEX
[4]  
[Anonymous], GEMC HYDR OX OBS TRE
[5]  
[Anonymous], METRIKA
[6]  
[Anonymous], 2002, AJCC CANC STAGING HD
[7]   Hepatobiliary Cancers [J].
Benson, Al B., III ;
Abrams, Thomas A. ;
Ben-Josef, Edgar ;
Bloomston, P. Mark ;
Botha, Jean F. ;
Clary, Bryan M. ;
Covey, Anne ;
Curley, Steven A. ;
D'Angelica, Michael I. ;
Davila, Rene ;
Ensminger, William D. ;
Gibbs, John F. ;
Laheru, Daniel ;
Malafa, Mokenge P. ;
Marrero, Jorge ;
Meranze, Steven G. ;
Mulvihill, Sean J. ;
Park, James O. ;
Posey, James A. ;
Sachdev, Jasgit ;
Salem, Riad ;
Sigurdson, Elin R. ;
Sofocleous, Constantinos .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2009, 7 (04) :350-391
[8]   Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment [J].
Blechacz, Boris ;
Gores, Gregory J. .
HEPATOLOGY, 2008, 48 (01) :308-321
[9]   Comparative Effectiveness of Hepatic Artery Based Therapies for Unresectable Intrahepatic Cholangiocarcinoma [J].
Boehm, Lucas M. ;
Jayakrishnan, Thejus T. ;
Miura, John T. ;
Zacharias, Anthony J. ;
Johnston, Fabian M. ;
Turaga, Kiran K. ;
Gamblin, T. Clark .
JOURNAL OF SURGICAL ONCOLOGY, 2015, 111 (02) :213-220
[10]  
Chambers J.M., 1991, Statistical Models in S